GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Cash Flow from Financing

Notable Labs (Notable Labs) Cash Flow from Financing : $7.82 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Notable Labs paid $0.00 Mil more to buy back shares than it received from issuing new shares. It spent $0.06 Mil paying down its debt. It received $3.98 Mil more from issuing preferred shares than it paid to buy back preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $3.90 Mil on other financial activities. In all, Notable Labs earned $7.82 Mil on financial activities for the six months ended in Dec. 2023.


Notable Labs Cash Flow from Financing Historical Data

The historical data trend for Notable Labs's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Cash Flow from Financing Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow from Financing
1.07 9.90 7.82

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Cash Flow from Financing 1.07 9.90 7.82

Notable Labs Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Notable Labs's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Notable Labs's Cash from Financing for the quarter that ended in Dec. 2023 is:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 was $7.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Notable Labs  (NAS:NTBL) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Notable Labs's issuance of stock for the six months ended in Dec. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Notable Labs's repurchase of stock for the six months ended in Dec. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Notable Labs's net issuance of debt for the six months ended in Dec. 2023 was $-0.06 Mil. Notable Labs spent $0.06 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Notable Labs's net issuance of preferred for the six months ended in Dec. 2023 was $3.98 Mil. Notable Labs received $3.98 Mil more from issuing preferred shares than it paid to buy back preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Notable Labs's cash flow for dividends for the six months ended in Dec. 2023 was $0.00 Mil. Notable Labs received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Notable Labs's other financing for the six months ended in Dec. 2023 was $3.90 Mil. Notable Labs received $3.90 Mil on other financial activities.


Notable Labs Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Notable Labs's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.